glasdegib
Selected indexed studies
- Glasdegib: First Global Approval. (Drugs, 2019) [PMID:30666593]
- Glasdegib. (, 2006) [PMID:30601609]
- Glasdegib. (, 2012) [PMID:31643486]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Glasdegib: First Global Approval. (2019) pubmed
- Glasdegib. (2006) pubmed
- Glasdegib. (2012) pubmed
- Glasdegib in newly diagnosed acute myeloid leukemia. (2021) pubmed
- Forsaken Pharmaceutical: Glasdegib in Acute Myeloid Leukemia and Myeloid Diseases. (2021) pubmed
- Acute myeloid leukemia management and research in 2025. (2025) pubmed
- Glasdegib combined with chemotherapy in the treatment of patients with acute myeloid leukemia: a comprehensive meta-analysis. (2025) pubmed
- An evaluation of glasdegib for the treatment of acute myelogenous leukemia. (2020) pubmed
- Update on glasdegib in acute myeloid leukemia - broadening horizons of Hedgehog pathway inhibitors. (2022) pubmed
- Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date. (2022) pubmed